Appendix 3B: New issue announcement, application for quotation of additional securities and agreement
180316_Appendix 3B and 3Y Notice
Appendix 3Y: Change of Director’s Interest Notice
180316_Change in Directors Interests
PharmAust new collaboration with leading cancer research institute on its MPL drug candidate
180312_PAA_ONJCRI collaboration_(clean)
PharmAust receives $354k R&D Tax Incentive Refund
180127_R&D Refund
Top 20 Shareholders Feb 2018
Top holder 20_Feb 2018
Results of General Meeting
180226_EGM Results
Appendix 4C and Shareholders Update (Q2, 2018 FY)
180131_Quarterley&Shareholders Update_PAA
